$2.07
+0.31
(+17.61%)▲
Revenue is up for the last 2 quarters, 11.92M → 12.86M (in $), with an average increase of 7.3% per quarter
Netprofit is down for the last 3 quarters, -28.05M → -39.24M (in $), with an average decrease of 18.9% per quarter
In the last 1 year, Dupont De Nemours Inc has given 48.0% return, outperforming this stock by 77.8%
13.77%
Downside
Day's Volatility :14.39%
Upside
0.72%
24.15%
Downside
52 Weeks Volatility :65.8%
Upside
54.9%
Period | Danimer Scientific Inc | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -13.03% | -5.2% | 0.0% |
6 Months | -32.79% | -1.0% | 0.0% |
1 Year | -29.83% | 15.5% | 6.3% |
3 Years | -91.2% | 23.4% | 17.3% |
Market Capitalization | 198.5M |
Book Value | $3.24 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -1.89 |
Wall Street Target Price | 4.6 |
Profit Margin | 0.0% |
Operating Margin TTM | -245.86% |
Return On Assets TTM | -10.12% |
Return On Equity TTM | -49.57% |
Revenue TTM | 50.6M |
Revenue Per Share TTM | 0.5 |
Quarterly Revenue Growth YOY | 1.3% |
Gross Profit TTM | 2.8M |
EBITDA | -97.7M |
Diluted Eps TTM | -1.89 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.38 |
EPS Estimate Next Year | -1.35 |
EPS Estimate Current Quarter | -0.36 |
EPS Estimate Next Quarter | -0.34 |
What analysts predicted
Upside of 122.22%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 32.3M | - |
Net Income | -19.5M | - |
Net Profit Margin | -60.33% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 47.3M | ↑ 46.34% |
Net Income | -12.6M | ↓ 35.57% |
Net Profit Margin | -26.56% | ↑ 33.77% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 58.7M | ↑ 24.12% |
Net Income | -60.1M | ↑ 378.06% |
Net Profit Margin | -102.31% | ↓ 75.75% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 53.2M | ↓ 9.41% |
Net Income | -179.8M | ↑ 199.06% |
Net Profit Margin | -337.78% | ↓ 235.47% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 14.7M | ↓ 16.84% |
Net Income | -26.4M | ↑ 112.0% |
Net Profit Margin | -178.97% | ↓ 108.76% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 12.7M | ↓ 13.84% |
Net Income | -30.4M | ↑ 15.38% |
Net Profit Margin | -239.67% | ↓ 60.7% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 10.4M | ↓ 17.75% |
Net Income | -94.9M | ↑ 211.63% |
Net Profit Margin | -908.08% | ↓ 668.41% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 15.3M | ↑ 46.67% |
Net Income | -28.1M | ↓ 70.43% |
Net Profit Margin | -183.05% | ↑ 725.03% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 11.9M | ↓ 22.17% |
Net Income | -36.6M | ↑ 30.62% |
Net Profit Margin | -307.22% | ↓ 124.17% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 12.9M | ↑ 7.87% |
Net Income | -39.2M | ↑ 7.1% |
Net Profit Margin | -305.02% | ↑ 2.2% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 144.6M | - |
Total Liabilities | 128.0M | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 546.2M | ↑ 277.8% |
Total Liabilities | 107.3M | ↓ 16.17% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 838.6M | ↑ 53.53% |
Total Liabilities | 338.3M | ↑ 215.32% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 712.3M | ↓ 15.06% |
Total Liabilities | 334.7M | ↓ 1.09% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 812.5M | ↓ 3.12% |
Total Liabilities | 324.5M | ↓ 4.08% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 790.7M | ↓ 2.68% |
Total Liabilities | 318.9M | ↓ 1.74% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 733.4M | ↓ 7.25% |
Total Liabilities | 341.7M | ↑ 7.15% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 712.3M | ↓ 2.88% |
Total Liabilities | 334.7M | ↓ 2.05% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 778.6M | ↑ 9.32% |
Total Liabilities | 423.0M | ↑ 26.4% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 744.3M | ↓ 4.42% |
Total Liabilities | 414.0M | ↓ 2.14% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 323.0K | - |
Investing Cash Flow | 2.8M | - |
Financing Cash Flow | -453.0K | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.7M | ↓ 617.96% |
Investing Cash Flow | -49.1M | ↓ 1846.46% |
Financing Cash Flow | 53.5M | ↓ 11909.71% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -13.8M | ↑ 724.69% |
Investing Cash Flow | -38.3M | ↓ 22.07% |
Financing Cash Flow | 422.7M | ↑ 690.08% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -63.0M | ↑ 356.35% |
Investing Cash Flow | -336.2M | ↑ 778.66% |
Financing Cash Flow | 306.2M | ↓ 27.56% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -61.8M | ↓ 1.79% |
Investing Cash Flow | -182.5M | ↓ 45.72% |
Financing Cash Flow | 21.8M | ↓ 92.9% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -17.6M | ↑ 13.42% |
Investing Cash Flow | -58.9M | ↓ 33.45% |
Financing Cash Flow | 78.0K | ↓ 99.96% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -19.8M | ↑ 12.4% |
Investing Cash Flow | -49.9M | ↓ 15.32% |
Financing Cash Flow | -7.0K | ↓ 108.97% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -20.2M | ↑ 2.03% |
Investing Cash Flow | -42.8M | ↓ 14.18% |
Financing Cash Flow | 23.0M | ↓ 328114.29% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -4.3M | ↓ 78.92% |
Investing Cash Flow | -30.9M | ↓ 27.94% |
Financing Cash Flow | -1.3M | ↓ 105.57% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -5.9M | ↑ 37.84% |
Investing Cash Flow | -16.4M | ↓ 46.85% |
Financing Cash Flow | 91.5M | ↓ 7251.48% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -15.3M | ↑ 160.63% |
Investing Cash Flow | -6.6M | ↓ 59.51% |
Financing Cash Flow | -6.5M | ↓ 107.11% |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Danimer Scientific Inc | 5.08% | -32.79% | -29.83% | -91.2% | -91.2% |
![]() Air Products & Chemicals Inc. | -4.1% | 1.32% | 21.77% | -4.85% | 67.27% |
![]() Linde Plc | -3.81% | 5.92% | 38.12% | 56.36% | 125.03% |
![]() Dupont De Nemours Inc | -3.12% | 5.61% | 48.0% | 34.44% | -42.24% |
![]() Sherwin-williams Company, The | -5.58% | 17.52% | 24.57% | 9.82% | 67.43% |
![]() Ecolab Inc. | -7.87% | 3.75% | 17.3% | -15.23% | 7.62% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Danimer Scientific Inc | 9.17 | NA | NA | -1.38 | -0.5 | -0.1 | 0.0 | 3.24 |
![]() Air Products & Chemicals Inc. | 29.33 | 29.33 | 1.92 | 11.48 | 0.15 | 0.06 | 0.02 | 63.64 |
![]() Linde Plc | 34.03 | 34.03 | 2.73 | 13.98 | 0.14 | 0.06 | 0.01 | 81.79 |
![]() Dupont De Nemours Inc | 36.74 | 36.74 | 1.64 | 4.3 | 0.04 | 0.03 | 0.02 | 56.91 |
![]() Sherwin-williams Company, The | 28.4 | 28.4 | 2.05 | 9.78 | 0.8 | 0.09 | 0.01 | 14.18 |
![]() Ecolab Inc. | 41.18 | 41.18 | 2.01 | 5.12 | 0.16 | 0.06 | 0.01 | 26.51 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Danimer Scientific Inc | Buy | $198.5M | -91.2% | 9.17 | 0.0% |
![]() Air Products & Chemicals Inc. | Buy | $63.7B | 67.27% | 29.33 | 16.88% |
![]() Linde Plc | Buy | $189.8B | 125.03% | 34.03 | 17.2% |
![]() Dupont De Nemours Inc | Buy | $34.2B | -42.24% | 36.74 | 37.65% |
![]() Sherwin-williams Company, The | Buy | $65.9B | 67.43% | 28.4 | 10.2% |
![]() Ecolab Inc. | Hold | $48.2B | 7.62% | 41.18 | 7.96% |
BlackRock Inc
Vanguard Group Inc
Teramo Advisors, LLC
Greenlight Capital, Inc
Amvescap Plc.
State Street Corporation
danimer scientific, producer of biopolymers in bainbridge, ga – manufactures pha bioplastics from renewable, natural resources. danimer plastics are 100% biodegradable and compostable, and equal or exceed petroleum-based plastic commodities for price and performance. danimer, formerly mhg (meredian holdings group), along with agrocrush, create bioplastic feedstock from cold pressed canola oil, enabling global brand owners to utilize environmentally responsible materials in products that consumers purchase every day. danimer makes commercial grade pha using world-class production systems, offering a scalable, durable, and cost effective material that reduces manufacturing dependence on non-renewable, diminishing resources. danimer also offers specialty toll manufacturing at their facility. danimer provides their state of the art production equipment, laboratories, material handling and logistics, as well as their fully trained and experienced staff to other companies.. danimer uses the
Organization | Danimer Scientific Inc |
Employees | 271 |
CEO | Mr. Stephen E. Croskrey |
Industry | Basic Materials |
Ishares Jp Morgan Em Corpora
$2.07
+17.61%
Valhi, Inc.
$2.07
+17.61%
Zim Integrated Shipping Serv
$2.07
+17.61%
Mercantile Bank Corp
$2.07
+17.61%
Lantern Pharma Inc
$2.07
+17.61%
Franklin Street Properties Corp
$2.07
+17.61%
Ars Pharmaceuticals Inc
$2.07
+17.61%
Citizens Financial Services Inc
$2.07
+17.61%
Fidelity D&d Bancorp Inc
$2.07
+17.61%